Date Filed | Type | Description |
05/08/2023 |
4
| Saluri Joseph (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns:
| Granted 39,200 options to buy
@ $0 |
|
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2020 |
4
| Saluri Joseph (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 30,000 options to buy
@ $0 |
|
07/02/2019 |
4
| Saluri Joseph (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 7,857 shares
@ $0 |
|
05/14/2019 |
4
| Saluri Joseph (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 8,487 shares
@ $0 |
|
04/26/2019 |
4
| Saluri Joseph (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 30,000 options to buy
@ $0 |
|
05/24/2018 |
4
| Saluri Joseph (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 15,000 options to buy
@ $0 |
|
07/20/2017 |
3
| Saluri Joseph (General Counsel, EVP-Corp Dev) has filed a Form 3 on Calyxt, Inc. |
05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/11/2016 |
4
| Saluri Joseph (Director) has filed a Form 4 on NEWLINK GENETICS CORP
Txns:
| Granted 17,773 options to buy
@ $10.78, valued at
$191.6k
Granted 4,783 options to buy
@ $10.78, valued at
$51.6k
|
|
05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/10/2013 |
4
| Saluri Joseph (Director) has filed a Form 4 on NEWLINK GENETICS CORP
Txns:
| Granted 12,000 options to buy
@ $14.71, valued at
$176.5k
|
|
11/06/2012 |
4
| Saluri Joseph (Director) has filed a Form 4 on NEWLINK GENETICS CORP
Txns:
| Granted 11,902 options to buy
@ $13.3, valued at
$158.3k
|
|
11/18/2011 |
4
| Saluri Joseph (Director) has filed a Form 4 on NEWLINK GENETICS CORP
Txns:
| Converted 8,142 shares
@ $0 Converted 8,142 shares
@ $0 Converted 15,000 preferred shares
@ $0 Converted 15,000 preferred shares
@ $0 |
|
11/14/2011 |
3/A
| Saluri Joseph (Director) has filed a Form 3/A on NEWLINK GENETICS CORP |